+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07589387

Improving Diabetes Care Through WHO HEARTS-D in Nigerian Primary Health Centers Building on Hypertension Treatment Success

Led by Washington University School of Medicine · Updated on 2026-10-16

2800

Participants Needed

10

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating diabetes management within the Hypertension Treatment in Nigeria HTN 2.0 Program, building on prior success in hypertension care. The study focuses on 10 primary healthcare centers in Nigerias Federal Capital Territory that previously implemented hypertension treatment. This phase uses the WHO HEARTS-D bundle to improve diabetes screening, diagnosis, treatment, and control in these centers. The study compares a 12-month pre-implementation period, which involves registry setup and providing glucometers without diabetes treatment training, to a 24-month implementation period. During implementation, the centers receive HEARTS-D training for community health extension workers, expand drug availability including metformin and glimepiride, and receive quarterly supportive supervision with audit-and-feedback. Glucometers and supplies are replenished throughout the study. Participants include adults with or at risk for diabetes attending these centers. Researchers will monitor blood glucose control, diabetes treatment rates, and availability of diabetes medicines and equipment. Assessments include routine blood glucose measurements and registration of diabetes patients. Supportive supervision visits and training aim to improve care quality over 36 months, with outcomes measured by changes in blood glucose control and treatment adherence.

CONDITIONS

Brief Title

Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

Research Team

D

Dike Ojji, MD

M

Mark Huffman, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here